Breaking News Instant updates and real-time market news.

SYF

Synchrony

$26.70

0.33 (1.25%)

, TJX

TJX

$74.23

-0.24 (-0.32%)

09:01
10/17/16
10/17
09:01
10/17/16
09:01

Synchrony announces extension of consumer financing program with TJX

Synchrony Financial (SYF) announced a multi-year renewal of its program to provide consumer financing for The TJX Companies (TJX). Synchrony Financial has provided consumer financing for TJX's Rewards Credit Card program in the U.S. since 2011.

SYF

Synchrony

$26.70

0.33 (1.25%)

TJX

TJX

$74.23

-0.24 (-0.32%)

  • 21

    Oct

SYF Synchrony
$26.70

0.33 (1.25%)

06/20/16
LEHM
06/20/16
DOWNGRADE
Target $20
LEHM
Underweight
SolarCity downgraded to Underweight from Equal Weight at Barclays
Barclays analyst Jon Windham downgraded SolarCity (SCTY) to Underweight saying he's more cautious on the U.S. residential solar space due to "credit quality warning signs" and the potential for higher rates in the second half of 2016. The analyst sees rising investor concerns over consumer credit quality after Synchrony Financial (SYF) last week announced an increase in net charge-off rates. While SolarCity and Sunrun (RUN) have strong consumer credit portfolios with average FICO scores of around 750, concerns on rates could weigh on the shares in the near term, Windham tells investors in a research note. He keeps a $20 price target for SolarCity shares. The seller of renewable energy closed Friday up 9c to $21.32. SolarEdge (SEDG) remains Windham's preferred name in the residential solar space. He lowered his price target for the shares to $28 from $35 and keeps an Overweight rating on the name. The analyst has an Equal Weight rating on Sunrun.
07/08/16
DBAB
07/08/16
NO CHANGE
Target $31.5
DBAB
Buy
Synchrony capital plan beat expectations, says Deutsche Bank
Deutsche Bank analyst David Ho says Synchrony's capital plan and DFAST stress test results exceeded his expectations. The better than expected dividend and buyback is "clearly a positive," and the stress test results demonstrate "resiliency of the model in a severe credit cycle," Ho tells investors in a research note. The analyst keeps a Buy rating on Synchrony with a $31.50 price target.
07/08/16
MSCO
07/08/16
NO CHANGE
Target $33
MSCO
Overweight
Synchrony capital plan should act as a positive catalyst, says Morgan Stanley
Morgan Stanley analyst Betsy Graseck said Syncrony's announcement for its first capital distribution, post the GE spinoff, implies a payout of $1.4B versus his estimate of $1.1B. The analyst said capital return is a key part of his Overweight thesis and should act as a positive catalysts for Syncrony shares.
10/10/16
WEDB
10/10/16
INITIATION
Target $31
WEDB
Outperform
Synchrony initiated with an Outperform at Wedbush
Wedbush analyst Henry Coffey initiated Synchrony with an Outperform and a $31 price target.
TJX TJX
$74.23

-0.24 (-0.32%)

08/17/16
WEDB
08/17/16
NO CHANGE
WEDB
TJX fundamentals still strong, says Wedbush
After TJX yesterday reported stronger than expected Q2 results but provided lower than expected Q3 guidance and the stock fell nearly 6%, Wedbush analyst Morry Brown remains upbeat on the company's fundamentals which he says have not changed. The analyst says that the wage pressures and adverse foreign exchange fluctuations reported by the company aren't new. Brown expects the company's SSS to continue to outperform that of its peers. He raised his price target on the shares to $84 from $82 and keeps an Outperform rating.
08/17/16
WELS
08/17/16
NO CHANGE
WELS
TJX 'bull thesis still in play,' says Wells Fargo
After TJX yesterday reported stronger than expected Q2 results but provided lower than expected Q3 guidance and the stock fell nearly 6%, Wells Fargo says that the wage pressures cited by the company are not worrisome. The firm thinks that the company's "top line fundamentals remains some of the strongest" in its sector Wells expects analysts to reduce their estimates for the company due to the wage pressures, but it recommends buying the shares "on any prolonged pullback" and keeps an Outperform rating.
08/17/16
RHCO
08/17/16
NO CHANGE
RHCO
TJX should be bought on weakness, says SunTrust
After TJX yesterday reported stronger than expected Q2 results but provided lower than expected Q3 guidance and the stock fell nearly 6%, SunTrust analyst Pamela Quintiliano says that the company's guidance is conservative. She noted that the company's results so far this quarter have been "solid," and says that it is well-positioned for continued market share gains. The analyst recommends buying the stock on weakness.
09/30/16
GUGG
09/30/16
INITIATION
GUGG
Buy
TJX coverage assumed with a Buy at Guggenheim
Guggenheim analyst Robert Drbul assumed coverage on TJX with a Buy and an $85 price target. He believes the off-price sector should continue to gain market share due to shifts in both vendor and consumer preferences and expects TJX to be one of the main beneficiaries.

TODAY'S FREE FLY STORIES

CLDR

Cloudera

10:15
04/28/17
04/28
10:15
04/28/17
10:15
Syndicate
Breaking Syndicate news story on Cloudera »

Cloudera IPO indicated to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Apr

10:15
04/28/17
04/28
10:15
04/28/17
10:15
General news
FX Action: The dollar »

FX Action: The dollar was…

ANTM

Anthem

$177.90

-0.4 (-0.22%)

, CI

Cigna

$155.93

-0.28 (-0.18%)

10:13
04/28/17
04/28
10:13
04/28/17
10:13
Periodicals
Breaking Periodicals news story on Anthem, Cigna »

Appeals court upholds…

ANTM

Anthem

$177.90

-0.4 (-0.22%)

CI

Cigna

$155.93

-0.28 (-0.18%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    May

  • 18

    May

RDUS

Radius Health

$38.72

-0.5 (-1.27%)

10:12
04/28/17
04/28
10:12
04/28/17
10:12
Hot Stocks
FDA website shows approval of Radius Health's Tymlos »

Shares of Radius Health…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    May

  • 03

    May

  • 02

    Jun

  • 30

    Jun

WDC

Western Digital

$85.71

1.1 (1.30%)

10:11
04/28/17
04/28
10:11
04/28/17
10:11
Recommendations
Western Digital analyst commentary  »

Western Digital price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VIX

Volatility Index S&P 500 Options

$10.50

0.14 (1.35%)

10:11
04/28/17
04/28
10:11
04/28/17
10:11
Options
Opening action in VIX August calls »

Opening action in VIX…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CLDR

Cloudera

10:10
04/28/17
04/28
10:10
04/28/17
10:10
Syndicate
Breaking Syndicate news story on Cloudera »

Cloudera IPO indicated to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Apr

NVS

Novartis

$76.70

-0.36 (-0.47%)

10:10
04/28/17
04/28
10:10
04/28/17
10:10
Hot Stocks
FDA approves Novartis' combination treatment for AML »

The U.S. Food and Drug…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    May

  • 05

    May

  • 07

    May

  • 06

    Jun

  • 26

    Jun

SWKS

Skyworks

$104.20

1.23 (1.19%)

, SSNLF

Samsung

10:09
04/28/17
04/28
10:09
04/28/17
10:09
Recommendations
Skyworks, Samsung analyst commentary  »

Skyworks price target…

SWKS

Skyworks

$104.20

1.23 (1.19%)

SSNLF

Samsung

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    May

  • 30

    May

RDUS

Radius Health

$38.72

-0.5 (-1.27%)

10:07
04/28/17
04/28
10:07
04/28/17
10:07
Hot Stocks
Radius Health jumps after FDA posts approval of Tymlos 

Reference Link

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    May

  • 03

    May

  • 02

    Jun

  • 30

    Jun

ORLY

O'Reilly Automotive

$257.19

-7.88 (-2.97%)

10:02
04/28/17
04/28
10:02
04/28/17
10:02
Recommendations
O'Reilly Automotive analyst commentary  »

O'Reilly Automotive…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Jun

MHK

Mohawk

$229.91

-8.97 (-3.76%)

10:01
04/28/17
04/28
10:01
04/28/17
10:01
Technical Analysis
Mohawk testing uptrend support line following earnings »

The shares were last at…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Apr

10:01
04/28/17
04/28
10:01
04/28/17
10:01
General news
Consumer Sentiment Index data reported »

April Consumer Sentiment…

CL

Colgate-Palmolive

$72.10

-1.2 (-1.64%)

10:01
04/28/17
04/28
10:01
04/28/17
10:01
Options
Call buyer in Colgate as shares fall on earnings »

Call buyer in Colgate as…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Apr

  • 31

    May

EEX

Emerald Expositions Events

10:00
04/28/17
04/28
10:00
04/28/17
10:00
Syndicate
Breaking Syndicate news story on Emerald Expositions Events »

Emerald Expositions…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Apr

IVC

Invacare

$14.85

1.6 (12.08%)

09:59
04/28/17
04/28
09:59
04/28/17
09:59
Upgrade
Invacare rating change  »

Invacare upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    May

  • 18

    May

CVNA

Carvana

09:58
04/28/17
04/28
09:58
04/28/17
09:58
Syndicate
Breaking Syndicate news story on Carvana »

Carvana opens at $13.50,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Apr

EFX

Equifax

$134.84

-1.35 (-0.99%)

09:56
04/28/17
04/28
09:56
04/28/17
09:56
Downgrade
Equifax rating change  »

Equifax downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    May

  • 04

    May

EEX

Emerald Expositions Events

09:55
04/28/17
04/28
09:55
04/28/17
09:55
Syndicate
Breaking Syndicate news story on Emerald Expositions Events »

Emerald Expositions…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Apr

09:55
04/28/17
04/28
09:55
04/28/17
09:55
General news
U.S. Chicago PMI increased 0.6 points to 58.3 in April »

U.S. Chicago PMI…

CSGP

CoStar Group

$236.71

17.35 (7.91%)

09:53
04/28/17
04/28
09:53
04/28/17
09:53
Recommendations
CoStar Group analyst commentary  »

CoStar Group price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jun

  • 21

    Jun

  • 22

    Jun

  • 22

    Jun

BOKF

BOK Financial

$85.04

-0.42 (-0.49%)

09:51
04/28/17
04/28
09:51
04/28/17
09:51
Upgrade
BOK Financial rating change  »

BOK Financial upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    May

OCLR

Oclaro

$7.93

0.01 (0.13%)

09:51
04/28/17
04/28
09:51
04/28/17
09:51
Recommendations
Oclaro analyst commentary  »

Oclaro estimates lowered …

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    May

  • 30

    May

BSX

Boston Scientific

$26.16

-0.02 (-0.08%)

09:51
04/28/17
04/28
09:51
04/28/17
09:51
Options
Active trading in Boston Scientific short-term calls »

Active trading in Boston…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    May

  • 07

    Jun

  • 27

    Jun

EEX

Emerald Expositions Events

09:50
04/28/17
04/28
09:50
04/28/17
09:50
Syndicate
Breaking Syndicate news story on Emerald Expositions Events »

Emerald Expositions…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Apr

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.